Vitrivax

Discovery Tools (Healthcare)Website
Current Valuation
$69.4M
As of November 17, 2025
Total Funding Raised
$38.2M
Across 1 round
Last Round
Later Stage VC

$29.4M

Last Funding
Nov 2025

Funding date

Capital Efficiency
1.82x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
November 17, 2025Later Stage VC (Series B)$29.4MN/A-
Valuation Analysis

Current Valuation Metrics

Vitrivax is currently valued at $69.4M as of November 17, 2025. The company has raised a total of $38.2M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.82x, Vitrivax has achieved a valuation that is 1.82 times the total capital raised.

Track Vitrivax Valuation Updates

Get notified when Vitrivax raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Vitrivax's valuation history, funding rounds, and growth metrics.

No credit card required

What is Vitrivax Worth in 2026?

Vitrivax is a leading private company in the Discovery Tools (Healthcare) sector. Track Vitrivax's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Vitrivax Valuation is Determined

Private company valuations like Vitrivax's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.